Project Grant R61DA063638
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $187,023 to Baystate Medical Center, Inc. in Massachusetts. The purpose is to conduct a mixed-methods study to determine the impact of the state's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program on healthcare utilization, costs, and overdose outcomes for individuals with opioid use disorder (OUD) upon release from...
- This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a clinical research hub to study the implementation and impact of a Medicaid Inmate Exclusion Policy (MIEP) waiver in 4 Massachusetts county jails. The $1,600,955 award, effective from Sep 1, 2025 to May 31, 2030, will be administered by the University of Massachusetts. The research aims to understand how the MIEP waiver, which...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $677,250 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Miami. The grant, awarded on June 15, 2025, supports the development and testing of the "Healthcare Empowerment and Advocacy for Recovery from Trafficking (HEART) Intervention" for implementation in syringe service programs. The project aims to engage women with experiences of...
- The National Institute on Drug Abuse (NIDA) has awarded a $731,275 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Massachusetts Medical School (UMMS) to support the "Supporting Treatment Access and Recovery in Re-entry (STAR-R)" study. The 5-year study will evaluate the effectiveness of the "Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice Version (MISSION-CJ)"...
- This federal Project Grant award for $188,995.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports research at the University of Pittsburgh focused on understanding, preventing, and treating substance use disorders. The project aims to develop novel interventions, explore neuroscientific mechanisms of addiction, and improve treatment strategies. The...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $823,882 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Oregon Health & Science University (OHSU) on July 15, 2025. The TEAM-UP: Tobacco Treatment Navigators Uniting with Primary Care project aims to implement and compare two outreach strategies, a person-based Outreach Navigator (ON) and a technology-based Interactive Patient Portal (IPP), to improve...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), has awarded a $663,662 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Iowa State University. The objective of this 5-year grant, awarded on June 1, 2025, is to develop and evaluate a trauma-informed substance use prevention intervention called the CASA Brief Intervention (CBI) that can be delivered by Court Appointed Special Advocates (CASAs) to youth in foster care....
- This federal Project Grant award of $769,708 from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), is for the "Drug Use and Addiction Research Programs" (CFDA 93.279). The award supports research to adapt and pilot test the Brief Negotiation Interview (BNI) for use among assault-injured emerging adults (ages 18-25) with alcohol and/or cannabis misuse who seek care in the emergency department setting. Key objectives include eliciting shared...
- This $105,076 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the neurocomputational basis of effort-based decision making (EBDM) in individuals with tobacco use disorder, tobacco and opioid use disorder, and healthy controls. The award will support research to characterize the neurocomputational basis of EBDM during a smoking cessation attempt. The project will computationally model...
- This Project Grant award of $288,107 from the National Institute on Drug Abuse (NIDA), which falls under CFDA 93.279 Drug Use and Addiction Research Programs, aims to develop a new generation of leaders in addiction research. The key products or services to be provided under this grant include: Establishing a predoctoral training program at the Scripps Research Institute to equip young scientists with technical skills and expertise in transdisciplinary "team science" needed to...
This Project Grant award of $472,370 from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), supports a study to implement and evaluate the Worker Input and Strategy Program (WISP) in residential addiction treatment facilities in Massachusetts. WISP is an evidence-based, participatory organizational intervention that aims to address stressful working conditions (e.g., lack of career progression, vicarious trauma) and improve workforce retention and patient care in these facilities. The award period runs from September 1, 2025 to August 31, 2027. The project is a partnership between the research team at the Harvard T.H. Chan School of Public Health, the Massachusetts Department of Public Health Bureau of Substance Addiction Services, and community-based addiction treatment stakeholders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $472.4k | 8/27/25 |